Related Experiment Video
Updated: Jun 18, 2025
08:50
How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
Published on: December 14, 2014
9.3K
Statin intolerance and the drucebo effect.
B Mugawar1, S Mcerlean2, P O' Connor1,3
1Department of Pharmacology, Trinity College Dublin School of Medicine, Trinity Centre for Health Sciences, St James's Hospital, Dublin, Ireland.
QJM : Monthly Journal of the Association of Physicians
|July 27, 2024
Summary
Statin intolerance, including statin-associated muscle symptoms, increases cardiovascular risk. Educating patients on the negative drucebo effect and statin benefits can improve adherence and reduce risks.
Area of Science:
- Cardiology
- Pharmacology
- Patient Adherence
Background:
- Hypercholesterolemia is a significant risk factor for atherosclerotic cardiovascular disease.
- Statins are the primary treatment for hypercholesterolemia.
- Statin intolerance (SI), especially statin-associated muscle symptoms (SAMS), leads to treatment discontinuation and elevated cardiovascular risk.
Purpose of the Study:
- To discuss the challenges of statin intolerance (SI).
- To explore the role of the negative drucebo effect in SAMS.
- To propose interventions for managing SI and improving statin adherence.
Main Methods:
- This commentary reviews existing literature on statin intolerance and the negative drucebo effect.
- It synthesizes information regarding patient education and adherence strategies.
- It discusses potential interventions to mitigate SI.
Main Results:
- A notable portion of SAMS may stem from the negative drucebo effect, influenced by patient expectations.
- Patient education on SI and the negative drucebo effect is crucial.
- Proactive management strategies can potentially improve statin adherence.
Conclusions:
- Addressing patient expectations and the negative drucebo effect is vital for managing SI.
- Effective patient education at the initiation of statin therapy can enhance adherence.
- Interventions targeting SI can mitigate cardiovascular risk associated with statin non-adherence.
Related Concept Videos
01:54The Placebo Effect
6.1K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.1K
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
613
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
613
02:07Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
01:11Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
01:21Drugs for Treatment of Constipation-Predominant IBS
151
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
151